Get an early start on your networking for South Summit 2024 by checking out our marketplace, where you can find profiles on all the Startups, Corporate Partners, Accelerators and Institutions who will be at the event.
I look for a relationships with a Working on Who can help my project via
Chronic pain affects around 1.5 billion people worldwide. Conventional treatment for chronic pain consists mostly of opioid narcotics. However, opioids have failed us as the US is currently undergoing an opioid epidemic. At Navega, we have developed a patented, non-permanent therapy to target pain that is non-addictive, highly specific, and long-term lasting. So how does this work? We were inspired by nature: there are humans that have a mutation in their genome that feel no pain whatsoever. We have imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way. In our proof-of-concept, we demonstrated that the mice that received our therapy had increased pain tolerance and lower pain levels.
If you have a proposal on some of these areas, we will gladly analyze:
